How much retatrutide should I take?

This site does not give dosing recommendations, but there is a public trial record. The Phase 2 trial gave adults with obesity weekly doses of 4, 8, or 12 milligrams for 48 weeks, with weight loss of 17.1%, 22.8%, and 24.2% respectively versus 2.1% on placebo. The larger Phase 3 TRIUMPH-1 trial found up to 28.3% weight loss at 80 weeks on the 12 milligram dose. Retatrutide remains investigational and is not an approved drug.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of glp-1 and metabolic peptides. Semaglutide, tirzepatide, retatrutide, and the rest of the incretin and glucagon receptor family.